Topic: breast cancer metastasis
The pivotal trial linked the tyrosine kinase inhibitor to reduced risk of progression and death in patients with and without brain metastases.
The data tee Seattle Genetics up to file for FDA approval of a TKI inhibitor it paid $614 million to acquire last year.
A drug that causes cancer cells to divide too rapidly and die was effective when combined with chemo in mouse models of triple-negative breast cancer.
A Boston Children's team has developed a method for knocking out the oncogene Lipocalin 2 using CRISPR carried by soft nanoparticles.
A team led by the Wyss Institute has created reversible platelets that they say may not only reduce blood clots but might also prevent cancer from spreading.
A Fred Hutch team has figured out how to kill dormant breast cancer cells using compounds that disrupt a protective signaling system.
In mouse models, a combo of diabetes treatment Avandia and cancer drug Mekinist turns some breast tumor cells into fat.
Camel-IDS will run a phase 1b/2 trial of its lead radiopharmaceutical in HER2-positive breast cancer that has spread to the brain.
Recent biotech developments include improved viral delivery vehicles for gene therapy and compounds that cripple resistant bacteria.
New biotech discoveries include CRISPR-induced conception and a biomarker for predicting breast cancer recurrences.